drugset / Trial / NCT00397566

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

NCT00397566 ↗

Phase 2 Withdrawn Bristol-Myers Squibb
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this clinical research study is to assess the safety, pharmacokinetics and pharmacodynamics of BMS-707035 in subjects infected with HIV-1

Timeline

Start
2007-02
Primary completion
—
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-707035 Small molecule — —